Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 22–28Cite as

Epidemiology of Antiphospholipid Syndrome

  • Chapter

Keywords

  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Patient
  • Lupus Anticoagulant
  • Recurrent Pregnancy Loss
  • Anticardiolipin Antibody

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  2. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440–443.

    CrossRef  PubMed  CAS  Google Scholar 

  3. Petri M, Akhtar S, Branch DW, Brey RL, Lockshin MD, Roubey RA. Evidence-based classification criteria for antiphospholipid antibody syndrome (APS) [abstract]. Arthritis Rheum 2003;48:S364.

    Google Scholar 

  4. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165:1272–1277.

    PubMed  CAS  Google Scholar 

  5. Infante RC, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991;325:1063–1066.

    CrossRef  Google Scholar 

  6. Perez MC, Wilson WA, Brown HL, Scopelitis E. Anticardiolipin antibodies in unselected pregnant women in relationship to fetal outcome. J Perinatol 1991;11:33–36.

    PubMed  CAS  Google Scholar 

  7. Rix P, Stentoft J, Aunsholt NA, Dueholm M, Tilma KA, Hoier-Madsen M. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population. Acta Obstet Gynecol Scand 1992;71:605–609.

    PubMed  CAS  Google Scholar 

  8. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909–913.

    PubMed  CAS  Google Scholar 

  9. Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J 1993;69:391–394.

    PubMed  CAS  Google Scholar 

  10. Juby AG, Davis P. Prevalence and disease associations of certain autoantibodies in elderly patients. Clin Invest Med 1998:21:4–11.

    PubMed  CAS  Google Scholar 

  11. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol 2000;27:2833–2837.

    PubMed  CAS  Google Scholar 

  12. Padmakumar K, Singh RR, Rai R, Malaviya AN, Saraya AK. Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations. Ann Rheum Dis 1990;49:986–989.

    PubMed  CAS  Google Scholar 

  13. Mayumi T, Nagasawa K, Inoguchi T, et al. Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant. Ann Rheum Dis 1991;50:543–547.

    PubMed  CAS  Google Scholar 

  14. McHugh NJ, Moye DAH, James IE, Sampson M, Maddison PJ. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. Ann Rheum Dis 1991;50:548–552.

    PubMed  CAS  Google Scholar 

  15. Wong K-L, Liu H-W, Ho K, Chan K, Wong R. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus. J Rheumatol 1991;18:1187–1192.

    PubMed  CAS  Google Scholar 

  16. Cervera R, Khamashta MA, Font J, et al., and the European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 1993;72:113–124.

    PubMed  CAS  Google Scholar 

  17. Jones HW, Ireland R, Senaldi G, et al. Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. Ann Rheum Dis 1991;50:173–175.

    PubMed  CAS  Google Scholar 

  18. Kutteh WH, Lyda EC, Abraham SM, Wacholtz MC. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993:60:449–455.

    PubMed  CAS  Google Scholar 

  19. Axtens RS, Miller MH, Littlejohn GO, Topliss DJ, Morand EF. Single anticardiolipin measurement in the routine management of patients with systemic lupus erythematosus. J Rheumatol 1994;21:91–93.

    PubMed  CAS  Google Scholar 

  20. Tsutsumi A, Matsuura E, Ichikawa K, et al. Antibodies to b2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466–1474.

    PubMed  CAS  Google Scholar 

  21. Tubach F, Hayem G, Marchand J-L, et al. IgG anti-β2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. J Rheumatol 2000;27:1437–1443.

    PubMed  CAS  Google Scholar 

  22. Bick RL, Jakway J, Baker WF Jr. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemost 1992;18:267–274.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Eschwege V, Peynaud-Debayle E, Wolf M. Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis 1998;9:429–434.

    PubMed  CAS  Google Scholar 

  24. Zanon E, Prandoni P, Vianello F, et al. Anti-β2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thromb Res 1999;96:269–274.

    CrossRef  PubMed  CAS  Google Scholar 

  25. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40:1190–1196.

    PubMed  CAS  Google Scholar 

  26. Czlonkowska A, Meurer M, Palasik W, Baranska-Gieruszczak M, Mendel T, Wierzchowska E. Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population? Acta Neurol Scand 1992;86:304–307.

    CrossRef  PubMed  CAS  Google Scholar 

  27. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189–193.

    PubMed  CAS  Google Scholar 

  28. de Jong AW, Hart W, Terburg M, Molenaar JL, Herbrink P, Hop WC. Cardiolipin antibodies and lupus anticoagulant in young patients with a cerebrovascular accident in the past. Neth J Med 1993;42:93–98.

    PubMed  Google Scholar 

  29. Ferro D, Quintarelli C, Rasura M, Antonini G, Violi F. Lupus anticoagulant and the fibrinolytic system in young patients with stroke. Stroke 1993;24:368–370.

    PubMed  CAS  Google Scholar 

  30. Tietjen GE, Levine SR, Brown E, Mascha E, Welch KMA. Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events. Arch Neurol 1993;50:833–836.

    PubMed  CAS  Google Scholar 

  31. Puurunen M, Manttari M, Manninen V, et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994;154:2605–2609.

    CrossRef  PubMed  CAS  Google Scholar 

  32. Vaarala O, Manttari M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23–27.

    PubMed  CAS  Google Scholar 

  33. Limaye V, Beltrame J, Cook R, Gillis D, Pile K. Evaluation of antibodies to beta2-glycoprotein 1 in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. Aust N Z J Med 1999;29:789–793.

    PubMed  CAS  Google Scholar 

  34. Fligelstone LJ, Cachia PG, Ralis H. Lupus anticoagulant in patients with peripheral vascular disease: a prospective study. Eur J Vasc Endovasc Surg 1995;9:277–283.

    CrossRef  PubMed  CAS  Google Scholar 

  35. Taylor M, Cauchi MN, Buchanan RRC. The lupus anticoagulant, anticardiolipin antibodies, and recurrent miscarriage. Am J Reprod Immunol 1990;23:33–36.

    PubMed  CAS  Google Scholar 

  36. Parazzini F, Acaia B, Faden D, et al. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991;77:854.

    PubMed  CAS  Google Scholar 

  37. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991;34:1231–1235.

    PubMed  CAS  Google Scholar 

  38. Aoki K, Hayashi Y, Hirao Y, Yagami Y. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss. Am J Reprod Immunol 1993;29:82–87.

    PubMed  CAS  Google Scholar 

  39. Bagger PV, Andersen V, Baslund B, et al. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE. Acta Obstet Gynecol Scand 1993;72:465–469.

    PubMed  CAS  Google Scholar 

  40. Toyoshima K, Makino T, Ozawa N, Umeuchi M, Nozawa S. Effect of anticardiolipin antibody in patients with recurrent fetal loss on thrombomodulin-dependent protein C activation. J Clin Lab Anal 1993;7:57–59.

    PubMed  CAS  Google Scholar 

  41. MacLean MA, Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994;101:103–106.

    PubMed  CAS  Google Scholar 

  42. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995;10:2001–2005.

    PubMed  CAS  Google Scholar 

  43. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Lupus 1996;5:587–592.

    PubMed  CAS  Google Scholar 

  44. Kumar KS, Jyothy A, Prakash MS, Rani HS, Reddy PP. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss. J Postgrad Med 2002;48:5–10.

    PubMed  CAS  Google Scholar 

  45. Maejima M, Fujii T, Okai T, Kozuma S, Shibata Y, Taketani Y. Beta2-glycoprotein I-dependent anticardiolipin antibody in early recurrent spontaneous abortion. Hum Reprod 1997;12:2140–2142.

    CrossRef  PubMed  CAS  Google Scholar 

  46. Matsumoto T, Sagawa N, Ihara Y, Kobayashi F, Itoh H, Mori T. Relationship between lupus anticoagulant (LAC) and pregnancy-induced hypertension. Reprod Fertil Dev 1995;7:1569–1571.

    CrossRef  PubMed  CAS  Google Scholar 

  47. Diz-Kucukkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001;98:1760–1764.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with SLE. J Rheumatol 2002;29:2531–2536.

    PubMed  CAS  Google Scholar 

  49. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993;20:1684–1693.

    PubMed  CAS  Google Scholar 

  50. Jouhikainen T, Stephansson E, Leirisalo-Repo M. Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus. Br J Rheumatol 1993;32:568–573.

    PubMed  CAS  Google Scholar 

  51. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303–308.

    PubMed  CAS  Google Scholar 

  52. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689–692.

    CrossRef  PubMed  CAS  Google Scholar 

  53. The Antiphospholipid Antibodies in Stroke Study Group (APASS). Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997;48:91–94.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Michelle Petri MD, MPH

Authors
  1. Michelle Petri MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Petri, M. (2006). Epidemiology of Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_3

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation